NCT06007417: An ongoing trial by Changchun GeneScience Pharmaceutical Co., Ltd.
This trial is ongoing. It must report results 4 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06007417 |
|---|---|
| Title | The Efficacy and Safety of Once-weekly PEG-somatropin (GenSci004) in Treatment-naive Children With Growth Hormone Deficiency: A Randomized, Open-label, Parallel-group, Active-Controlled, Non-inferiority Phase 3 Study (ELEVATE) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 1, 2023 |
| Completion date | May 1, 2025 |
| Required reporting date | May 1, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |